Follow us on:

Shield Therapeutics positioned for profitability with Viatris deal and its additional capital (VIDEO)

Shield Therapeutics (LON:STX) is the topic of conversation when Dr Martin Hall joins DirectorsTalk Interviews.

Martin summarises a number of announcements made by the company recently, explains Accrufer has performed in the US, a co-promotion deal with Viatris, changes made to the forecast and with the share price languishing what Martin expects to happen from here.

Shield Therapeutics plc is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR.

You might also enjoy reading Duke Capital Record cashflows in FY’24 (Video)

Find more news, interviews, share price & company profile here for:

Hardman & Co

Share this interview

Other Interviews

NB Private Equity Key Takeaway from Capital Markets Day (Video) December 3, 2024
Duke Capital Equity raise and third-party capital update (Video) November 19, 2024
ICG Enterprise Trust Operating companies’ widening margins and strong EBITDA growth (VIDEO) November 12, 2024
Real Estate Credit Investments Understanding the Discount, Its Rise, and Future Prospects (VIDEO) November 1, 2024
NB Private Equity Partners, the Unique Value of Co-Investment in Private Equity (VIDEO) October 28, 2024
Apax Global Alpha 1H24 Deal activity rebounding (VIDEO) October 14, 2024
Chesnara plc 2024 interim results a steady performance (VIDEO) October 11, 2024
Surface Transforms Plc: Strategic Moves and Market Potential with Mike Foster September 3, 2024
H&T Group plc 1H24 results curates egg of good and bad (VIDEO) August 30, 2024
Putting H&T Group’s pawnbroking business into a global perspective (VIDEO) August 14, 2024

More News

Surface Transforms Plc: Strategic Moves and Market Potential with Mike Foster September 3, 2024
Volta Finance What we can learn from the Report and Accounts (VIDEO) February 12, 2024
Real Estate Credit Investments – Actively managing the portfolio to the latest market opportunities (VIDEO) November 27, 2023
Structured products investing: Volta Finance in Hardman Q&A (LON:VTA) May 9, 2023
China investment opportunities: In-depth analysis of Fidelity China Special Situations (LON:FCSS) April 13, 2023
Fidelity European Trust outperforms peers for dividend income investing March 15, 2023
Real Estate Credit Investments portfolio yield has risen by a tenth in recent months (LON:RECI) December 5, 2022
Fidelity European Trust resilience pays dividends LON:FEV (VIDEO) December 2, 2022
Performance, prospects and risks analysed for Fidelity Asia investment trust (LON:FAS) November 21, 2022
Income investing stock Volta Finance cash flows at near-record levels (LON:VTA) October 13, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.